Lysosome‐Targeting Protein Degradation Through Endocytosis Pathway Triggered by Polyvalent Nano‐Chimera for AD TherapyXiaorong Wang, Huile Gao, Shiqin Chen et al.|Advanced Materials|2024Cited by 34
Intranasal Carrier-Free Nanomodulator Addresses Both Symptomatology and Etiology of Alzheimer’s Disease by Restoring Neuron Plasticity and Reprogramming Lesion MicroenvironmentWenqin Yang, Huile Gao, Yulong Shi et al.|ACS Nano|2024Cited by 26
Counteracting Alzheimer's disease via normalizing neurovascular unit with a self-regulated multi-functional nano-modulatorXue Xia, Huile Gao, Ya Wei et al.|Acta Pharmaceutica Sinica B|2024Cited by 18
Asprosin attenuates diabetic cardiomyopathy through inhibiting autophagy mediated by AMPK/mTOR/ULK1 pathwayYuan Wang, Wentao Liu, Chen Liu et al.|American Journal of Physiology-Cell Physiology|2025Cited by 6
Asprosin Aggravates Tubular Epithelial Cell Injury and Phenotypic Transformation via Mitochondrial Dynamics Disorder Mediated by Excessive Drp1 SUMOylation in Diabetic Nephropathy MiceQianqian Huang, Xiaowei Xiong, Sheng Chen et al.|Advanced Science|2025Cited by 2